Cue Health Inc., a San Diego, CA-based health technology company, closed a $235m financing round.
Backers included Perceptive Advisors, MSD Capital, and Koch Strategic Platforms, a subsidiary of Koch Industries, existing investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Decheng Capital, Cavu Ventures, ACME Capital, and others.
The company intends to use the funds to accelerate growth.
Led by Ayub Khattak, co-founder and CEO, Cue is a health technology company that enables people to manage their health through real-time, actionable and connected health data. The company offers individuals and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point-of-care, all in a handly device.
The Cue Health Monitoring System, together with the Cue COVID-19 Test Kit, is used for COVID-19 testing in enterprises, schools, nursing homes, hospitals, physicians’ offices, dental clinics, sports leagues, live event venues, hotels, federal and state agencies, and other settings around the country.
The company plans to develop a suite of offerings to address respiratory health, sexual health, cardiac and metabolic health, women’s health, men’s health, and chronic disease management by connecting diagnostics with telemedicine.